Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

Open access

Abstract

Diffuse gliomas are up till now graded based upon morphology. Recent findings indicate that isocitrate dehydrogenase (IDH) mutation status defines biologically distinct groups of tumors. The role of tumor grade and mitotic index in patient outcome has not been evaluated following stratification by IDH mutation status. To address this, we interrogated 558 WHO grade II-III diffuse gliomas for IDH1/2 mutations and investigated the prognostic impact of WHO grade within IDH-mutant and IDH-wild type tumor subsets independently. The prognostic impact of grade was modest in IDH-mutant [hazard ratio (HR) = 1.21, 95 % confidence interval (CI) = 0.91-1.61] compared to IDH-wild type tumors (HR = 1.74, 95 % CI = 0.95-3.16). Using a dichotomized mitotic index cut-off of 4/1000 tumor cells, we found that while mitotic index was significantly associated with outcome in IDH-wild type tumors (log-rank p < 0.0001, HR = 4.41, 95 % CI = 2.55-7.63), it was not associated with outcome in IDH-mutant tumors (log-rank p = 0.5157, HR = 1.10, 95 % CI = 0.80-1.51), and could demonstrate a statistical interaction (p < 0.0001) between IDH mutation and mitotic index (i.e., suggesting that the effect of mitotic index on patient outcome is dependent on IDH mutation status). Patient age, an established prognostic factor in diffuse glioma, was significantly associated with outcome only in the IDH-wild type subset, and consistent with prior data, 1p/19q co-deletion conferred improved outcome in the IDH-mutant co…

Overview

Integrity signals

Registry

Crossref · 10.1007/s00401-015-1398-z

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 78 references

Research works printed but not linked: 1

  1. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK (1997) Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 79(7):1381–1393 · doi:10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w

Cited by

See all 362

Metadata

Authors
Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., Armstrong, T. S., Sulman, E. P., Cahill, D. P., Vera-Bolanos, E., Yuan, Y., Reijneveld, J. C., Ylstra, B., Wesseling, P., & Aldape, K. D.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Baylor College of Medicine (US)
  • Massachusetts General Hospital (US)
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
  • Radboud University Medical Center (NL)
Corresponding author
  • Olar, Adriana
  • Aldape, Kenneth D.
Venue
Acta Neuropathologica
Published
2015-02-21
Volume
129
Issue
4
Pages
585-596
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2070603556
Cited by
354
References
78
Citations by year
2026: 10 · 2025: 25 · 2024: 31 · 2023: 26 · 2022: 39 · 2021: 23 · 2020: 52 · 2019: 36 · 2018: 41 · 2017: 32 · 2016: 23 · 2015: 13
FWCI
20.34
Type
journal article
Language
en
Open access
Licence
  • other-oa
  • www.springer.com/tdm (tdm)
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Radboud Universiteit
  • Vrije Universiteit Amsterdam
  • Radboud Universitair Medisch Centrum
  • National Institutes of Health
  • National Cancer Institute (T32CA163185, P50CA127001, P50CA165962)
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
Keywords
diffuse glioma, IDH mutation, IDH1, IDH2, WHO grade, mitotic index, overall survival, prognostic factors, 1p/19q codeletion, tumor grading, patient age, statistical interaction
MeSH terms
Adolescent, Adult, Aged, Brain Neoplasms, Chromosome Deletion, Chromosomes, Human, Pair 1, Female, Glioma, Humans, Isocitrate Dehydrogenase, Male, Middle Aged, Mitotic Index, Mutation, Retrospective Studies, Survival Analysis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. https://app.cochat.ai/papers/10.1007/s00401-015-1398-z
The paper
Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., Armstrong, T. S., Sulman, E. P., Cahill, D. P., Vera-Bolanos, E., Yuan, Y., Reijneveld, J. C., Ylstra, B., Wesseling, P., & Aldape, K. D. (2015). IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathologica. https://doi.org/10.1007/s00401-015-1398-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.